Document is current

Any future updates will be listed below

In silico ADMET profiling of Docetaxel and development of camel milk derived liposomes nanocarriers for sustained release of Docetaxel in triple negative breast cancer

Crossref DOI link: https://doi.org/10.1038/s41598-023-50878-8

Published Online: 2024-01-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark